# US Medical Cannabis Market

> US Medical Cannabis Market Research Report: Size, Share, Trend Analysis By Product Type (Solids, Dissolvable/ Powders, Oil, Ointments & Creams), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Route of Administration (Inhalation, Oral, Topical), By Applications (Pain Management, Neurological Health Management, Mental Health Management), By Pain Management Sub-segments (Neuropathic Pain, Cancer, Inflammatory Pain) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.86%
- **2024:** $ 4,000 Million
- **2025:** $ 4,394.4 Million
- **2035:** $ 11,250 Million
- **Key Players:** Canopy Growth Corporation (CA), Aurora Cannabis Inc. (CA), Tilray Brands, Inc. (CA), Cronos Group Inc. (CA), Green Thumb Industries Inc. (US), Curaleaf Holdings, Inc. (US), Trulieve Cannabis Corp. (US), Harvest Health & Recreation Inc. (US)

**Report ID:** MRFR/MED/11321-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-medical-cannabis-market-12846

---

## Market Summary

## **US Medical Cannabis Market**

As per MRFR analysis, the US Medical Cannabis Market Size was estimated at 4.01 (USD Billion) in 2023. The US Medical Cannabis Market Industry is expected to grow from 5(USD Billion) in 2024 to 15 (USD Billion) by 2035. The US Medical Cannabis Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035).

### **Key US Medical Cannabis Market Trends Highlighted**

The US Medical Cannabis Market is experiencing significant growth driven by evolving state regulations, increasing acceptance of cannabis for medical purposes, and the push for research on its therapeutic benefits. Many states have enacted legal frameworks that allow for the medical use of cannabis, reflecting a shift in public opinion and governmental support. This change has opened doors for a variety of cannabis-based products aimed at treating conditions such as chronic pain, epilepsy, and multiple sclerosis, among others.

The opportunity to explore and capture the market lies in expanding product lines, particularly in developing new formulations and delivery methods such as edibles, topicals, and tinctures, which appeal to a diverse consumer base.

Recent trends highlight an increase in the interest surrounding cannabinoids beyond THC and CBD, fostering innovation in product development. States like California and Colorado are leading examples of how a well-regulated market can thrive, influencing other states to consider similar legislative measures. Demand for sustainable and organic cannabis products is also rising, as consumers become more health-conscious. As further studies emerge on the efficacy of [medical cannabis](../../../reports/medical-cannabis-market-8368), there is a growing potential for partnerships between healthcare providers and cannabis companies, ultimately aiming to integrate these products into conventional medical solutions.

Access to medical cannabis continues to evolve, with many states pursuing ways to increase patient access and simplify the recommendation process, making it easier for patients to benefit from cannabis therapy.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **US Medical Cannabis Market Drivers**

#### **Increasing Acceptance of Medical Cannabis in Healthcare**

The acceptance of medical cannabis as a legitimate treatment option is rapidly gaining momentum in the United States, driven by evolving perspectives from healthcare professionals and patients. According to a survey conducted by the American Medical Association, over 70% of American doctors now support the use of cannabis for therapeutic purposes. This shift represents a significant change from previous stigmas, contributing to the growth of the US Medical Cannabis Market Industry.

Furthermore, legislative changes across various states have also fostered an environment where medical cannabis can be legally prescribed and used to treat conditions such as chronic pain, epilepsy, and multiple sclerosis.

In 2021, the American Academy of Family Physicians published findings indicating that approximately 40% of patients with chronic pain have turned to cannabis as an alternative to opioids, which aligns with the increasing patient demand for cannabis-based treatments. As more states reevaluate their cannabis policies and as healthcare practitioners become more knowledgeable about the benefits of cannabis, the market is poised for substantial growth, projected to expand significantly in the coming years.

#### **Rising Incidence of Chronic Diseases**

The prevalence of chronic diseases among the US population is a significant driver of the US Medical Cannabis Market Industry. According to the Centers for Disease Control and Prevention (CDC), about 60% of American adults live with at least one chronic condition, and nearly 40% have two or more chronic diseases. Medical cannabis has shown promise in relieving symptoms associated with various chronic conditions, including arthritis, diabetes, and heart disease. This situation is further compounded by data from the National Institute of Health, which suggests a growing recognition of medical cannabis among healthcare providers as an effective adjunct therapy.

Consequently, as the aging population increases and the number of individuals suffering from chronic illnesses rises, the demand for medical cannabis is expected to see a parallel increase, thus driving market growth.

#### **Favorable Regulatory Environment**

The US has witnessed a continuous evolution in the regulatory framework surrounding medical cannabis, significantly impacting the US Medical Cannabis Market Industry. States have increasingly adopted laws permitting the medical use of cannabis, with 38 states and the District of Columbia legalizing it for medicinal purposes as of 2023. This changing legal landscape not only enhances market access for producers but also encourages investments in Research and Development (R&D) of cannabis-based therapies.

For instance, recent policy changes in states like New York and California have streamlined the approval process for medical cannabis products, setting a precedent for other states to follow.

Furthermore, federal re-evaluations such as the potential reclassification of cannabis under the Controlled Substances Act could foster a more comprehensive regulatory environment, thus benefiting manufacturers and consumers alike. The increasing number of dispensaries and medical practitioners certified to recommend cannabis will likely contribute to market expansion.

#### **Growing Interest in Cannabis-related Research**

Research and Development in the field of medical cannabis have increased significantly, fostering advancements in understanding its therapeutic potential. The National Institutes of Health (NIH) reported a 200% increase in cannabis-related studies over the past five years, underscoring the scientific community's growing interest in exploring cannabis' medicinal properties. This surge in research is facilitated by grants and funding from institutions like the NIH, which are focused on investigating the efficacy of cannabis in treating a variety of conditions, including PTSD, anxiety, and chronic pain.

Furthermore, universities and research hospitals have begun collaborating with private cannabis companies to develop new cannabis-based treatments, which enhances product innovation. The increasing publication of peer-reviewed studies contributes to public awareness and acceptance, thereby driving demand in the US Medical Cannabis Market Industry.

### **US Medical Cannabis Market Segment Insights**

#### **Medical Cannabis Market Product Type Insights**

The US Medical Cannabis Market has showcased a diverse array of product types, reflecting the varying preferences and therapeutic needs of consumers. Among these product types, Solids have gained traction due to their convenience and ease of dosage, making them a preferred choice for patients seeking consistent consumption. Dissolvable items and Powders represent an innovative approach, allowing for versatile applications and rapid onset of relief, often appealing to those who prioritize discreet and fast-acting solutions.

Oils, characterized by their high bioavailability, dominate as a form of medical cannabis that offers flexibility in usage, whether consumed directly or added to foods and beverages.

On the other hand, Ointments and Creams have carved out a significant space in the market, as they allow localized application, catering well to patients with specific ailments such as skin conditions or joint pain. Each of these product types reflects the evolving landscape of the medical cannabis industry, driven by consumer demand for targeted and effective solutions. The growth of the US Medical Cannabis Market can be attributed to various factors, including increased patient awareness, supportive legislation, and advancements in product formulation, all contributing to a more informed customer base that seeks out specific benefits from different product types.

As the industry progresses, the distinct attributes of each product type could play a crucial role in shaping market dynamics, leading to a more educated market segmentation that aligns with patient needs and preferences. The continued emphasis on research and development within this segment is likely to result in new formulations and technologies, further enhancing the effectiveness and appeal of various product types in the medical cannabis landscape.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

#### **Medical Cannabis Market Derivative Insights**

The Derivative segment of the US Medical Cannabis Market plays a crucial role in addressing the diverse needs of patients seeking therapeutic benefits. This segment comprises major components such as Cannabidiol (CBD) and Tetrahydrocannabinol (THC), which are recognized for their distinct medicinal properties. CBD is widely acknowledged for its non-psychoactive benefits, commonly used in managing conditions such as anxiety, epilepsy, and chronic pain, thereby gaining substantial traction among health-conscious consumers. On the other hand, THC is known for its psychoactive effects, often utilized in pain management and appetite stimulation, particularly for patients undergoing treatments such as chemotherapy.

The growing acceptance of cannabis-derived products, coupled with legislative reforms in the US, is driving demand in the Derivative segment. Furthermore, ongoing research is likely to unveil new therapeutic applications, contributing to the expansion of this segment. The combination of these factors, along with increased public awareness and the push for natural treatment alternatives, is fostering significant growth and innovation within the US Medical Cannabis Market, ultimately enhancing patient care and accessibility to effective medicinal options.

#### **Medical Cannabis Market Route of Administration Insights**

The Route of Administration segment within the US Medical Cannabis Market holds crucial importance as it significantly influences the effectiveness, onset, and patient experience of cannabis therapies. Inhalation, commonly used for its rapid absorption and effect, is preferred by many patients seeking immediate relief, especially for conditions like chronic pain and anxiety. Meanwhile, the oral administration route has gained traction, offering convenience and the ability to precisely dose, making it popular among those preferring a discreet consumption method.

Additionally, topical applications are emerging as a significant player in this segment, particularly appealing for localized pain relief and skincare solutions without the psychoactive effects associated with other consumption methods.

As patients become more educated about the benefits of different administration routes, the US Medical Cannabis Market segmentation will likely continue to evolve, shaped by shifting consumer preferences and a growing body of research highlighting the efficacy of specific methods. The emphasis on personalized medicine and the diverse needs of patients underscore the importance of route of administration, driving innovation and expanding product offerings within the broader market landscape. Furthermore, regulatory developments and increased acceptance of medical cannabis in the US contribute to the growing demand across these administration methods.

#### **Medical Cannabis Market Application Insights**

The Application segment of the US Medical Cannabis Market focuses on various therapeutic uses, primarily Pain Management, Neurological Health Management, and Mental Health Management. Pain Management is notably significant due to the rising prevalence of chronic pain conditions across the US population, which has led to a shift in treatment preferences towards cannabis-based therapies as alternatives to opioid medications. Neurological Health Management has gained attention as cannabis is increasingly recognized for its potential benefits in managing conditions like epilepsy and multiple sclerosis, appealing to patients seeking non-pharmaceutical interventions.

Additionally, Mental Health Management is crucial, particularly as awareness grows around mental health issues and the therapeutic effects of cannabis on anxiety and depression, making it a dominate focus for both consumers and healthcare providers.

These applications are supported by evolving legislation and increasing acceptance within the medical community, driving a robust demand for medicinal cannabis products in the US. Overall, each of these areas showcases the versatility and potential of the US Medical Cannabis Market, as it responds to growing patient needs and healthcare challenges.

#### **Medical Cannabis Market Pain Management Sub-segments Insights**

The US Medical Cannabis Market is increasingly recognized for its role in pain management, with various conditions driving its segmentation. Among these, neuropathic pain, cancer-related pain, and inflammatory pain stand out as critical focuses. Neuropathic pain affects millions of Americans, often resulting from conditions like diabetes or injury, and has been challenging to treat with conventional medications. The cancer pain segment is significant, as patients often experience persistent pain due to the disease itself or its treatment, creating a strong demand for effective relief options.

Inflammatory pain, commonly associated with conditions such as arthritis and other autoimmune disorders, represents another essential aspect of the pain management landscape.

The therapeutic properties of cannabis, particularly cannabinoids, are gaining attention for their potential to provide relief from these complex pain conditions, reflecting a growing acceptance of medical cannabis as a viable treatment option. As the US healthcare system continues to evolve, the insights into the US Medical Cannabis Market segmentation underscore the importance of developing targeted therapies to effectively address these prevalent health issues.

#### **Medical Cannabis Market Distribution Channel Insights**

The Distribution Channel segment of the US Medical Cannabis Market is a vital component influencing the accessibility and reach of cannabis products across the nation. With the increasing acceptance of medical cannabis in the United States, various avenues have emerged for distribution, prominently including Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Hospital pharmacies play a crucial role, particularly in providing medications to inpatient settings and ensuring that patients receive their prescriptions in a controlled environment.

Retail pharmacies, on the other hand, hold a significant share in this market due to widespread accessibility, allowing patients to conveniently obtain their cannabis products alongside traditional medications. The Online Pharmacy segment has experienced a surge in popularity, driven by the growing trend of e-commerce and the need for discreet purchasing options, which enhances patient privacy.

Each distribution channel contributes uniquely to the overall growth of the US Medical Cannabis Market, supported by evolving regulations and patients' increasing demand for effective therapeutic options. As the market expands, understanding these channels will be essential for industry stakeholders looking to capitalize on emerging opportunities while addressing challenges such as regulatory compliance and logistical hurdles.

### **US Medical Cannabis Market Key Players and Competitive Insights**

The US Medical Cannabis Market has experienced significant growth in recent years, driven by changing regulations, increased acceptance of cannabis for medicinal purposes, and evolving consumer preferences. The competitive landscape is characterized by a mix of established players and new entrants, all striving to capitalize on the expanding market. Companies are increasingly focusing on product innovation, strategic partnerships, and mergers and acquisitions to enhance their market share and improve their product offerings. The landscape is also shaped by the varying state laws governing cannabis usage, necessitating adaptability among companies to comply with diverse regulations while meeting consumer needs.

As competition intensifies, businesses are investing heavily in branding, marketing, and customer engagement strategies to differentiate themselves in an increasingly crowded marketplace.

GTI has established a robust presence in the US Medical Cannabis Market, embodying key strengths that contribute to its competitive edge. The company's extensive operational footprint allows it to strategically position dispensaries and cultivation sites across various states, ensuring accessibility and convenience for patients. GTI is recognized for its commitment to high-quality products, which has earned it a loyal customer base. The company's focus on research and development enables it to innovate effectively, introducing new strains and products tailored to the specific needs of medical cannabis patients.

Furthermore, GTI's operational efficiency and strong management team bolster its competitive position, allowing it to navigate the complexities of the cannabis market with relative ease.

Green Thumb Industries has emerged as a prominent player in the US Medical Cannabis Market, showcasing a comprehensive range of products and services that cater to the diverse needs of consumers. The company operates numerous dispensaries and cultivation facilities, ensuring a significant market presence in key states. Green Thumb Industries is known for its high-quality cannabis products, including flower, edibles, and topicals, which resonate well with patients seeking therapeutic options. Strategic mergers and acquisitions have further strengthened the company's position, allowing it to expand quickly and enhance its product offerings.

Their commitment to social responsibility, alongside a focus on patient education and community engagement, sets Green Thumb Industries apart in a competitive landscape. The combination of innovative product development, effective distribution channels, and patient-centric services solidifies Green Thumb Industries' stature in the US Medical Cannabis Market.

### **Key Companies in the US Medical Cannabis Market Include**

- [GTI](https://investors.gtigrows.com/investors/news-and-events/press-releases/press-release-details/2024/RISE-Dispensaries-to-Launch-Legal-Cannabis-Sales-at-All-Five-RISE-Ohio-Locations-on-August-6/default.aspx)
- Green Thumb Industries
- Acreage Holdings
- Cresco Labs
- MedMen Enterprises
- Harvest Health and Recreation
- Columbia Care
- Curaleaf
- Charlotte's Web Holdings
- Ascend Wellness Holdings
- Planet 13 Holdings
- Trulieve
- Verano Holdings
- Liberty Health Sciences

### **US Medical Cannabis Market Industry Developments**

The US Medical Cannabis Market has seen significant developments as legalization efforts continue across various states. Recent legislative changes in states like Maryland and New York have expanded access to medical cannabis, further mainstreaming its use for conditions such as chronic pain and anxiety. Companies such as Green Thumb Industries and Curaleaf have been actively increasing their footprints through new dispensaries and product launches. Mergers and acquisitions have been noteworthy, with Columbia Care acquiring Green Leaf Medical in September 2023, aimed at expanding its market presence in the mid-Atlantic region.

Cresco Labs also announced in August 2023 its intention to acquire Columbia Care, enhancing its operational capabilities and reach.

The market is experiencing growth, with businesses like Harvest Health and Recreation recording increases in stock valuations amid rising investor interest. Additionally, Charlotte's Web Holdings has reported strong sales figures in its hemp-derived CBD products. Over the past two to three years, states have increasingly recognized the medicinal benefits of cannabis, leading to a more robust regulatory environment and higher consumer acceptance as seen by significant revenue increases in states that have legalized medical cannabis.

### **US Medical Cannabis Market Segmentation Insights**

#### **Medical Cannabis Market Product Type Outlook**

- Solids
- Dissolvable/ Powders
- Oil
- Ointments & Creams

#### **Medical Cannabis Market Derivative Outlook**

- Cannabidiol
- Tetrahydrocannabinol

#### **Medical Cannabis Market Route of Administration Outlook**

- Inhalation
- Oral
- Topical

#### **Medical Cannabis Market Application Outlook**

- Pain Management
- Neurological Health Management
- Mental Health Management

#### **Medical Cannabis Market Pain Management Sub-segments Outlook**

- Neuropathic Pain
- Cancer
- Inflammatory Pain

#### **Medical Cannabis Market Distribution Channel Outlook**

- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy

## Market Drivers

### Growing Patient Demand

The medical cannabis market is experiencing a notable increase in patient demand, driven by a growing recognition of its therapeutic benefits. Conditions such as chronic pain, epilepsy, and multiple sclerosis have led to a surge in prescriptions. Recent data indicates that approximately 3 million patients in the US are currently utilizing medical cannabis, reflecting a growth rate of around 20% annually. This rising patient base is likely to propel the medical cannabis market forward, as more individuals seek alternative treatments. Furthermore, the increasing awareness of cannabis as a viable option for symptom management is fostering a more favorable environment for the industry. As healthcare providers become more educated about the benefits of medical cannabis, the market is expected to expand, potentially leading to new product developments and innovations tailored to patient needs.

### Public Awareness and Education

Public awareness and education regarding the medical cannabis market are crucial for its growth. As more information becomes available about the benefits and uses of medical cannabis, public perception is shifting positively. Educational campaigns by advocacy groups and healthcare professionals are helping to dispel myths and misconceptions surrounding cannabis use. This increased understanding is likely to lead to higher acceptance among patients and healthcare providers alike. In 2025, surveys indicate that approximately 70% of the population supports the use of medical cannabis, reflecting a significant change in attitudes. As public awareness continues to grow, the medical cannabis market may see an influx of new patients seeking treatment options, thereby driving demand and expanding the market further.

### Increased Investment and Funding

Investment in the medical cannabis market is on the rise, as venture capitalists and institutional investors recognize the potential for substantial returns. In 2025, the market is projected to reach a valuation of $30 billion, attracting significant financial interest. This influx of capital is likely to support research, product development, and marketing efforts within the industry. Furthermore, the establishment of partnerships between cannabis companies and pharmaceutical firms may enhance credibility and facilitate the development of new therapies. As funding continues to flow into the medical cannabis market, it is expected that innovation will accelerate, leading to a broader range of products and services that cater to diverse patient needs. This trend may also encourage the entry of new players into the market, further stimulating competition and growth.

### Regulatory Changes and Frameworks

The evolving regulatory landscape surrounding the medical cannabis market is a critical driver of growth. States are increasingly implementing frameworks that facilitate access to medical cannabis for patients. As of November 2025, over 30 states have legalized medical cannabis, with varying degrees of regulation. This regulatory acceptance is likely to enhance market stability and encourage investment in the industry. Moreover, the establishment of clear guidelines for cultivation, distribution, and sales is expected to attract more businesses to the medical cannabis market. The potential for federal legalization could further amplify this trend, as it may lead to a more unified regulatory approach across the country. Consequently, the medical cannabis market is poised for significant expansion as regulations become more favorable and accessible.

### Advancements in Product Development

Innovations in product development are playing a pivotal role in shaping the medical cannabis market. Companies are increasingly focusing on creating a diverse range of products, including oils, edibles, and topicals, to cater to varying patient preferences. The introduction of standardized dosing and formulations is likely to enhance patient safety and efficacy, making medical cannabis more appealing to a broader audience. Additionally, advancements in extraction and cultivation techniques are expected to improve product quality and consistency. As the medical cannabis market evolves, the emphasis on research and development will likely lead to the emergence of novel therapies and delivery methods. This focus on innovation may not only attract new consumers but also solidify the market's position within the healthcare landscape.

## Future Outlook

The [Medical Cannabis Market](https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368) is projected to grow at a 9.86% CAGR from 2025 to 2035, driven by increasing legalization, expanding patient access, and advancements in product development.

**New opportunities:**

- Development of telehealth platforms for cannabis consultations Investment in automated cultivation technologies Expansion of cannabinoid-based pharmaceuticals for chronic pain management

By 2035, the medical cannabis market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Application: Pain Management (Largest) vs. Neurological Disorders (Fastest-Growing)

In the application segment of the US medical cannabis market, Pain Management currently dominates, capturing a significant share due to the increasing prevalence of chronic pain conditions among adults. Neurological Disorders, while smaller in comparison, are gaining traction as awareness of cannabis's therapeutic benefits in conditions such as epilepsy and multiple sclerosis spreads, indicating a growing acceptance and demand within this specific category.

Growth trends in this segment are fueled by ongoing research highlighting the efficacy of cannabis in treating various ailments. As more patients and healthcare providers recognize its potential, there is a notable increase in product offerings tailored for conditions like Mental Health Disorders and Inflammatory Conditions. The evolving regulatory landscape also supports market expansion, contributing to a shift in perception towards medical cannabis as a viable treatment option.

Pain Management (Dominant) vs. Inflammatory Conditions (Emerging)

Pain Management remains the dominant application in the US medical cannabis market, primarily focused on providing relief for chronic pain conditions such as arthritis and back pain. Its extensive usage is reinforced by a wide variety of product formulations, including oils, edibles, and topicals, allowing for personalized treatment options. In contrast, Inflammatory Conditions represent an emerging application area, with a growing body of evidence supporting the anti-inflammatory properties of cannabinoids. As research continues to evolve, potential applications for conditions like Crohn's disease and rheumatoid arthritis are gaining interest, indicating a shift towards more diverse product offerings that cater to this evolving consumer base.

### By Product Type: Flower (Largest) vs. Oils (Fastest-Growing)

In the US medical cannabis market, the product type segment is characterized by varying market shares among its constituents. Flower remains the largest segment, strongly favored by consumers for its traditional consumption method and wide-ranging effects. Other segments, such as oils and edibles, also hold significant shares, catering to specific preferences and consumption methods. Tinctures and topicals, while valuable, tend to have smaller market shares compared to these leading segments.

Growth trends indicate that oils are emerging as the fastest-growing product type. This shift is driven by increased awareness of their therapeutic benefits, as well as the convenience they offer. Consumers are finding oils to be an appealing option for precise dosing. Additionally, the rise of edibles reflects a growing preference for alternative consumption methods and flavors, further diversifying the market and catering to various consumer needs.

Flower: Dominant vs. Oils: Emerging

Flower stands as the dominant product type within the US medical cannabis market, celebrated for its versatility and established user base. It is favored for its natural appeal and availability in various strains, each offering unique therapeutic effects. On the flip side, oils are emerging rapidly, appealing to newer consumers seeking ease of use and precision in dosing. The rising demand for tinctures and topicals also highlights a shift towards alternative consumption methods. As consumers become more educated about the different products and their effects, both flower and oils will likely continue to capture substantial attention, thus shaping market dynamics in the coming years.

### By Distribution Channel: Dispensaries (Largest) vs. Online Stores (Fastest-Growing)

In the medical cannabis market, dispensaries hold the largest market share, accounting for a significant portion of sales as they provide direct access for patients. Pharmacies also play a crucial role, though their share is smaller compared to dispensaries and online stores. Online stores are gaining traction, especially as consumers become more comfortable with purchasing medical cannabis products online, which is shaping the distribution dynamics of the market.

Growth trends show an increasing preference for online shopping due to convenience and wider product selection, driving online stores to emerge as the fastest-growing segment. This growth is fueled by advancements in technology, improved e-commerce platforms, and a shift in consumer behavior towards digital interactions. Dispensaries are expected to remain strong, but online stores are positioning themselves to capture a larger share in the coming years.

Dispensaries: Dominant vs. Online Stores: Emerging

Dispensaries dominate the distribution channel in the medical cannabis market, providing patients with a wide range of products and expert guidance from staff. They serve as vital touchpoints for customer education and community engagement, contributing to their strong market presence. In contrast, online stores are rapidly emerging due to the growing trend of e-commerce, offering convenience and accessibility. They cater to tech-savvy consumers looking for discreet purchasing options and often provide a broader selection of products. Both segments exhibit unique characteristics; however, the shift towards online shopping indicates that the market dynamics are evolving, with online stores potentially increasing their market share in the future.

### By Formulation: Cannabinoid-Based (Largest) vs. Synthetic (Fastest-Growing)

In the US medical cannabis market, the formulation segment is predominantly led by Cannabinoid-Based products, which capture the largest market share thanks to their well-established therapeutic effects and broad acceptance among patients. Herbal-Based formulations also contribute significantly, appealing to consumers seeking traditional remedies; however, they represent a smaller share compared to Cannabinoid-Based options. Synthetic formulations, while currently holding a minor market share, are emerging strongly as advancements in pharmaceutical sciences pave the way for innovative treatment solutions.

The growth of the formulation segment is driven by increasing patient acceptance, regulatory advancements, and a growing emphasis on personalized medicine. Specifically, Cannabinoid-Based products benefit from extensive research backing their efficacy for various medical conditions, leading to higher demand. Meanwhile, Synthetic formulations are rapidly gaining traction as pharmaceutical companies invest in research and development, optimizing delivery mechanisms and improving formulations that cater to complex patient needs.

Cannabinoid-Based (Dominant) vs. Herbal-Based (Emerging)

Cannabinoid-Based formulations are the dominant force within the US medical cannabis market, characterized by their extraction from cannabis plants and the availability of various cannabinoids such as CBD and THC. Their high efficacy and versatility in treating a range of illnesses have established them as first-line therapy options for many patients, leading to widespread adoption. On the other hand, Herbal-Based formulations are emerging, reflecting a growing preference for natural and holistic treatment options. These products tap into traditional medicine approaches and are sought after for their perceived safety and fewer side effects. Although they hold a smaller market share, their increasing popularity signifies a shift in consumer behavior, as many patients explore alternatives to conventional pharmaceuticals.

## Competitive Benchmarking

The [medical cannabis market](https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368) in the US is characterized by a dynamic competitive landscape, driven by evolving consumer preferences, regulatory changes, and increasing acceptance of cannabis for therapeutic use. Key players such as Green Thumb Industries Inc. (US), Curaleaf Holdings, Inc. (US), and Tilray Brands, Inc. (CA) are strategically positioning themselves through innovation, regional expansion, and partnerships. Green Thumb Industries, for instance, focuses on product diversification and enhancing its retail footprint, which collectively shapes a competitive environment that is increasingly focused on quality and consumer experience. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The market structure appears moderately fragmented, with a mix of large-scale operators and smaller niche players. This fragmentation allows for a variety of product offerings and competitive strategies, as key players leverage their strengths to capture market share. In September 2025, Curaleaf Holdings, Inc. (US) announced a strategic partnership with a leading technology firm to enhance its digital marketing capabilities. This move is significant as it reflects the growing importance of digital transformation in reaching consumers and optimizing sales channels. By integrating advanced analytics and targeted marketing strategies, Curaleaf aims to strengthen its brand presence and customer engagement in a competitive market. In October 2025, Green Thumb Industries Inc. (US) launched a new line of wellness products aimed at the growing health-conscious consumer segment. This initiative underscores the company's commitment to innovation and meeting the diverse needs of consumers. By expanding its product range, Green Thumb not only enhances its market position but also addresses the increasing demand for health-oriented cannabis products. In August 2025, Tilray Brands, Inc. (CA) completed the acquisition of a regional cannabis producer, which is expected to bolster its supply chain and distribution capabilities. This acquisition is strategically important as it allows Tilray to expand its operational footprint and improve its market access, particularly in underserved regions. Such moves indicate a trend towards consolidation in the market, as companies seek to enhance their competitive edge through scale and efficiency. As of November 2025, current trends in the medical cannabis market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence in operations. Strategic alliances are increasingly shaping the landscape, enabling companies to leverage complementary strengths and resources. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability, as companies strive to meet the sophisticated demands of consumers.

## Recent News & Developments

The US Medical Cannabis Market has seen significant developments as legalization efforts continue across various states. Recent legislative changes in states like Maryland and New York have expanded access to medical cannabis, further mainstreaming its use for conditions such as chronic pain and anxiety. Companies such as Green Thumb Industries and Curaleaf have been actively increasing their footprints through new dispensaries and product launches. Mergers and acquisitions have been noteworthy, with Columbia Care acquiring Green Leaf Medical in September 2023, aimed at expanding its market presence in the mid-Atlantic region.

Cresco Labs also announced in August 2023 its intention to acquire Columbia Care, enhancing its operational capabilities and reach.

The market is experiencing growth, with businesses like Harvest Health and Recreation recording increases in stock valuations amid rising investor interest. Additionally, Charlotte's Web Holdings has reported strong sales figures in its hemp-derived CBD products. Over the past two to three years, states have increasingly recognized the medicinal benefits of cannabis, leading to a more robust regulatory environment and higher consumer acceptance as seen by significant revenue increases in states that have legalized medical cannabis.

## Report Scope

| MARKET SIZE 2024 | 4000.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 4394.4(USD Million) |
| MARKET SIZE 2035 | 11250.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.86% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Canopy Growth Corporation (CA), Aurora Cannabis Inc. (CA), Tilray Brands, Inc. (CA), Cronos Group Inc. (CA), Green Thumb Industries Inc. (US), Curaleaf Holdings, Inc. (US), Trulieve Cannabis Corp. (US), Harvest Health & Recreation Inc. (US) |
| Segments Covered | Application, Product Type, Distribution Channel, Formulation |
| Key Market Opportunities | Expansion of telehealth services enhances patient access to medical cannabis consultations and prescriptions. |
| Key Market Dynamics | Evolving regulatory frameworks and consumer preferences drive innovation and competition in the medical cannabis market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US medical cannabis market?**
A: The market valuation was $4000.0 Million in 2024.

**Q: What is the projected market size for the US medical cannabis market by 2035?**
A: The market is expected to reach $11250.0 Million by 2035.

**Q: What is the expected CAGR for the US medical cannabis market during the forecast period 2025 - 2035?**
A: The expected CAGR is 9.86% during the forecast period.

**Q: Which segment generated the highest revenue in the US medical cannabis market in 2024?**
A: The Pain Management segment generated $1600.0 Million in 2024.

**Q: What are the projected revenues for the Inflammatory Conditions segment by 2035?**
A: The Inflammatory Conditions segment is projected to reach $3000.0 Million by 2035.

**Q: Which product type is anticipated to have the highest growth in the US medical cannabis market?**
A: The Flower product type is expected to grow from $1200.0 Million to $3200.0 Million by 2035.

**Q: What distribution channel had the highest revenue in 2024?**
A: Dispensaries generated $2000.0 Million in revenue in 2024.

**Q: What is the projected revenue for Online Stores in the US medical cannabis market by 2035?**
A: Online Stores are projected to reach $2000.0 Million by 2035.

**Q: Which formulation type is expected to dominate the market by 2035?**
A: Cannabinoid-Based formulations are projected to grow from $2000.0 Million to $6000.0 Million by 2035.

**Q: Who are the key players in the US medical cannabis market?**
A: Key players include Canopy Growth Corporation, Aurora Cannabis Inc., and Curaleaf Holdings, Inc.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-medical-cannabis-market-12846*